Forward Pharma A Price Prediction
| FWPDelisted Stock | USD 2.56 0.00 0.00% |
Oversold Vs Overbought
47
Oversold | Overbought |
Using Forward Pharma hype-based prediction, you can estimate the value of Forward Pharma A from the perspective of Forward Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Forward Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Forward because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Forward Pharma after-hype prediction price | USD 2.56 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Forward |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Forward Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Forward Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of Forward Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Forward Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Forward Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Forward Pharma Estimiated After-Hype Price Volatility
In the context of predicting Forward Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Forward Pharma's historical news coverage. Forward Pharma's after-hype downside and upside margins for the prediction period are 2.56 and 2.56, respectively. We have considered Forward Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Forward Pharma is very steady at this time. Analysis and calculation of next after-hype price of Forward Pharma A is based on 3 months time horizon.
Forward Pharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Forward Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Forward Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Forward Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 2 Events / Month | 5 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.56 | 2.56 | 0.00 |
|
Forward Pharma Hype Timeline
On the 1st of December Forward Pharma A is traded for 2.56. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Forward is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Forward Pharma is about 0.0%, with the expected price after the next announcement by competition of 2.56. The company has price-to-book (P/B) ratio of 0.31. Some equities with similar Price to Book (P/B) outperform the market in the long run. Forward Pharma A has Price/Earnings To Growth (PEG) ratio of 0.13. The entity recorded a loss per share of 0.27. The firm last dividend was issued on the 12th of September 2017. Forward Pharma had 1:7 split on the 6th of December 2019. Considering the 90-day investment horizon the next anticipated press release will be in a few days. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.Forward Pharma Related Hype Analysis
Having access to credible news sources related to Forward Pharma's direct competition is more important than ever and may enhance your ability to predict Forward Pharma's future price movements. Getting to know how Forward Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Forward Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CNTA | Centessa Pharmaceuticals PLC | (0.58) | 9 per month | 3.08 | 0.09 | 8.37 | (5.69) | 21.09 | |
| OMHE | Omni Health | 0.00 | 2 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| XPOF | Xponential Fitness | (0.33) | 10 per month | 2.85 | 0.05 | 5.96 | (5.28) | 35.52 | |
| VALN | Valneva SE ADR | 0.11 | 3 per month | 0.00 | (0.41) | 3.20 | (5.86) | 12.07 | |
| RYAAY | Ryanair Holdings PLC | 0.43 | 7 per month | 1.94 | (0.03) | 3.14 | (3.25) | 8.74 | |
| HOFT | Hooker Furniture | 0.06 | 8 per month | 2.69 | 0.06 | 5.56 | (4.81) | 12.49 | |
| SSY | SunLink Health Systems | 0.01 | 5 per month | 3.46 | 0 | 7.59 | (8.05) | 20.59 |
Forward Pharma Additional Predictive Modules
Most predictive techniques to examine Forward price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Forward using various technical indicators. When you analyze Forward charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Forward Pharma Predictive Indicators
The successful prediction of Forward Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Forward Pharma A, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Forward Pharma based on analysis of Forward Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Forward Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Forward Pharma's related companies.
Story Coverage note for Forward Pharma
The number of cover stories for Forward Pharma depends on current market conditions and Forward Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Forward Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Forward Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Forward Pharma Short Properties
Forward Pharma's future price predictability will typically decrease when Forward Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Forward Pharma A often depends not only on the future outlook of the potential Forward Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Forward Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 7 M | |
| Cash And Short Term Investments | 70.8 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Forward Stock
If you are still planning to invest in Forward Pharma A check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Forward Pharma's history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |